<DOC>
	<DOCNO>NCT00946530</DOCNO>
	<brief_summary>The aim study demonstrate efficacy time exposure bright light treatment disturb nighttime sleep daytime wake community-dwelling dementia patient caregiver , determine genetic relationship memory problem sleep problem</brief_summary>
	<brief_title>Light Treatment Sleep/Wake Disturbances Alzheimer 's Disease</brief_title>
	<detailed_description>1 . Efficacy : Up 4 week morning bright light exposure efficacious morning dim light consolidate nighttime sleep assess actigraphy . 2 . Predictors response : We expect primary predictor treatment response initial MMSE score . Secondary predictor include baseline sleep/wake circadian parameter age . 3 . Effectiveness : Bright light treatment effective dim light improve quality life . 4 . An understanding genetic marker memory and/or sleep problem .</detailed_description>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<criteria>Alzheimer 's Disease Patients : Stanford Alzheimer 's Disease Core Center member potential member , diagnostic criterion meet probable AD , live caregiver willing participate protocol Noninstitutionalized Caregivers : Living home AD patient willing participate protocol Alzheimer 's Disease Patients : History manic bipolar disorder Prior bright light treatment Irregular non24 hour sleep/wake cycle Positive result multistaged RLS/PLMD Medical/Ophthalmologic Exclusions RDI &gt; 20 overnight EdenTraceÂ® record Caregivers : History manic bipolar disorder Medical/Ophthalmologic Exclusions</criteria>
	<gender>All</gender>
	<minimum_age>55 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>